Recruiting Stroke Studies in San Francisco
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
The primary objective is to establish the efficacy of intra-arterial (IA) mechanical thrombectomy (MT) with extracranial proximal carotid artery acute stenting versus non-stenting approaches in patien...
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
The purpose of this study is to evaluate the safety and tolerability of ascending doses (Part A) and selected doses (Part B) of BB-031 in acute ischemic stroke patients presenting within 24 hours of s...
About Stroke Clinical Trials in San Francisco
A stroke occurs when blood flow to part of the brain is interrupted or reduced, depriving brain tissue of oxygen and nutrients. It is a leading cause of disability and death. Rapid treatment is critical, and prevention focuses on managing risk factors like hypertension and atrial fibrillation.
There are currently 2 stroke clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 560 participants. Research is being sponsored by Mercy Health Ohio, Basking Biosciences, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Stroke Clinical Trials in San Francisco — FAQ
Are there stroke clinical trials in San Francisco?
Yes, there are 2 stroke clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in San Francisco?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.
Are clinical trials in San Francisco free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.
What stroke treatments are being tested?
The 2 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for stroke.
Data updated March 2, 2026 from ClinicalTrials.gov